galcanezumab
Selected indexed studies
- Galcanezumab. (, 2012) [PMID:31643470]
- Galcanezumab. (, 2006) [PMID:30372007]
- Galcanezumab for the prevention of migraine. (Pain Manag, 2021) [PMID:33291980]
_Worker-drafted node — pending editorial review._
Connections
galcanezumab is a side effect of
Sources
- Galcanezumab. (2012) pubmed
- Galcanezumab. (2006) pubmed
- Galcanezumab for the prevention of migraine. (2021) pubmed
- Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study. (2018) pubmed
- Galcanezumab: First Global Approval. (2018) pubmed
- Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial. (2024) pubmed
- [Galcanezumab for episodic and chronic cluster headache]. (2023) pubmed
- Galcanezumab for the prevention of cluster headache. (2020) pubmed
- A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study. (2024) pubmed
- Galcanezumab in the Treatment of Migraine: A Narrative Review of Real-World Studies. (2023) pubmed